SNORA71B: A Potential Drug Target and Biomarker (G26776)

Target Name: SNORA71B

NCBI ID: G26776

SNORA71B

Other Name(s): RNU71B | small nucleolar RNA, H/ACA box 71B | U71b | Small nucleolar RNA, H/ACA box 71B

SNORA71B: A Potential Drug Target and Biomarker

SNORA71B (RNU71B) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the RNA-protein subfamily and is characterized by the presence of a N-terminal RNA domain and a C-terminal protein domain.

SNORA71B is involved in various cellular processes that are essential for normal development, wound healing, and tissue repair. It has been shown to play a role in the regulation of cell proliferation, cell migration, and the development of cancer.

One of the most promising aspects of SNORA71B is its potential as a drug target. The N-terminal RNA domain of SNORA71B has been shown to be involved in the regulation of gene expression, and this function has led to the identification of numerous potential drug targets.

One of the most promising drug targets for SNORA71B is the inhibition of its N-terminal RNA domain. This has been shown to have therapeutic effects on various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Another potential drug target for SNORA71B is its ability to regulate cell migration. SNORA71B has been shown to play a role in the regulation of cell migration and has been shown to be involved in the development of various diseases, including cancer.

In addition to its potential as a drug target, SNORA71B has also been shown to be a potential biomarker. Its expression has been shown to be regulated by various factors, including growth factors, pro-inflammatory cytokines, and neurotrophic factors. This has led to the identification of SNORA71B as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

In conclusion, SNORA71B is a protein that has the potential to be a drug target and a biomarker. Its N-terminal RNA domain and its ability to regulate cell proliferation, cell migration, and the development of cancer make it an attractive target for drug development. Further research is needed to fully understand the function of SNORA71B and its potential as a drug and biomarker.

Protein Name: Small Nucleolar RNA, H/ACA Box 71B

The "SNORA71B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORA71B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets